Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
11/2005
11/02/2005EP1501525B1 Method for producing preparations rich in tocotrienol
11/02/2005EP1501515B1 Triaryl-oxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitors
11/02/2005EP1357930B1 Histidine-rich glycoprotein (hrgp) for inhibiting angiogenesis
11/02/2005EP1332149B1 Glycerophosphoinositol derivatives as modulators of cytosolic a2 phospholipase
11/02/2005EP1307181B1 Novel compositions of minoxidil
11/02/2005EP1278719B1 Naphthamide neurokinin antagonists for use as medicaments
11/02/2005EP1246807B1 Novel hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines
11/02/2005EP1237902B1 Halogenated sulphamate-, phosphonate-, thiophosphonate-, sulphonate- and sulphonamide- compounds as inhibitors of steroid sulphatase
11/02/2005EP1080095B1 Modulators of protein tyrosine phosphatases (ptpases)
11/02/2005EP0951537B1 Recombinant collagen produced by plants, methods for obtaining them and uses
11/02/2005CN1692127A TACI antibodies and uses thereof
11/02/2005CN1692123A Compounds, compositions and methods for treatment of inflammatory diseases and conditions
11/02/2005CN1692115A Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group
11/02/2005CN1691947A Method of treating or preventing immune mediated disorders and pharmaceutical formulation for use therein
11/02/2005CN1691945A Use of rapamycin for inhibiting of cell death
11/02/2005CN1690057A Selenophen derivatives and their use for prevention and/or treatment of diseases relative to protein aging
11/02/2005CN1225478C Embedded CD25-resisting monoclonal antibody and its coding sequence and application
11/02/2005CN1225266C Medicine for treating wind rheumatism, injuries from falls and ulcer in opening of sore
11/02/2005CN1225254C Medicinal composition for treating psoriasis, its preparation process and use
11/02/2005CN1225247C Storage stable tretinoin and 4-hydroxy anisole contg. topical compsn.
11/02/2005CN1225243C Fluid for dispelling prickly heat and dermatitis and preparation method
11/02/2005CN1225238C Herbal acne-eliminating cream
11/01/2005US6960692 Diaryl sulfide derivative, addition salt thereof, and immunosuppressant
11/01/2005US6960685 histone deacetylase; antiproliferative agents; psoriasis, cancer; N-Hydroxy-2-(4-Isopropyl-phenylcarbamoyl)-methoxy)-acetamide
11/01/2005US6960683 Antiinflammatory agents; autoimmune diseases; cardiovascular disorders
11/01/2005US6960674 A lipoxin compound for treating polymorphoneutrophil (PMN) inflammation
11/01/2005US6960614 Oxygenated esters of 4-lodo phenylamino benzhydroxamic acids
11/01/2005US6960612 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith
11/01/2005US6960609 Analgesics; central nervous system disorders; gastrointestinal disorder; therapy for drug abruse ; antiinflammatory agents
11/01/2005US6960605 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging
11/01/2005US6960602 Piperidine derivatives as modulators of chemokine receptors
11/01/2005US6960597 Aza-bridged-bicyclic amino acid derivatives as α4 integrin antagonists
11/01/2005US6960590 Orally active salts with tyrosine kinase activity
11/01/2005US6960585 For therapy of inflammatory and immune diseases
11/01/2005US6960581 1-amino-2-hydroxy-butane or 2-hydroxy-butanamide derivatives
11/01/2005US6960444 Transcriptional mediators of blood vessel development and endothelial differentiation
11/01/2005US6960359 Comprising cedrol, cedrenol, farnesol, patchouli alcohol or vetiverol; antiallergic agents and atopic dermatitis preventives
11/01/2005US6960354 Dry powder cosmetics; mixing or milling phospholipids, an alpha-hydroxycarboxylic acid or salt (salicylate) and a xanthine (caffeine, aminophylline, theophylline, theobromine); improved bioavailability; reduced irritancy
11/01/2005CA2383351C Xanthine derivatives as selective antagonists of a2b adenosine receptors
10/2005
10/27/2005WO2005099760A1 Solid pharmaceutical preparation
10/27/2005WO2005099759A1 Medicine for prevention and/or treatment of arteriosclerosis
10/27/2005WO2005099734A1 Lipase inhibitor containing water extract from leaf of hardy rubber tree
10/27/2005WO2005099733A1 Vegetable antibacterial composition
10/27/2005WO2005099731A1 Antibacterial agent derived from galenical and composition for external application containing the same
10/27/2005WO2005099728A1 Pharmaceutical compositions from beard lichen (usnea barbata) and st. john's wort (hypericum perforatum) and their use
10/27/2005WO2005099686A1 Edible composition having effects of promoting the production and release of calcitonin gene-related peptide
10/27/2005WO2005079770A8 Use of a compound modulating at least one receiver selected in a group comprising an interleukin 8 type b receptor and pacap-1 receptor for preparing a pharmaceutical composition for rosacea treatment
10/27/2005WO2005007699A8 Human antibody molecules for il-13
10/27/2005WO2004072284A8 Modulation of insulin like growth factor i receptor expression
10/27/2005WO2003023008A8 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/27/2005US20050239852 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors
10/27/2005US20050239851 Substituted benzoxazoles as estrogenic agents
10/27/2005US20050239835 controlling weight gain; 1-(1-amino-2-phenylethylcarbonyl)-4-cyclohexylpiperidine compounds
10/27/2005US20050239786 Triazole derivatives as tachykinin receptor antagonists
10/27/2005US20050239777 Quinazoline derivatives and pharmaceutical compositions containing them
10/27/2005US20050239776 Tachykinin receptor antagonists
10/27/2005US20050239773 1-[9-(3-Phenyl-allyl)-3,9 diaza-bicyclo[4.2.1]non-3-yl]-propan-1-one; analgesic; great selectivity to mu receptor; analgesic; pain relief, drug dependence, alcoholism; side effect reduction
10/27/2005US20050239755 External preparation for inhibiting keloid formation
10/27/2005US20050239749 External preparation
10/27/2005US20050239741 use in the field of neuroprotection and cancer treatment (neuroblastoma tumors)
10/27/2005US20050239732 Immunostimulatory nucleic acid molecules
10/27/2005US20050239724 Skin penetration enhancing components
10/27/2005US20050239710 Peptide that inhibits matrix metalloproteinase-2; incorporated into lotion or wound dressing; can promote the growth of fibroblasts, prevent skin wrinkling, treat scarring, promote smooth healthy skin
10/27/2005US20050239698 placental growth factor (PLGF) capable of promoting neovascularization in the treatment of diseases and pathological alterations involving the cutaneous or subcutaneous connective tissue, scleroderma and skin ageing due to exposure to chemicals or solar radiation
10/27/2005US20050239170 Alpha-MSH related compounds and methods of use
10/27/2005US20050239141 Modified antibody variable domains
10/27/2005US20050239103 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
10/27/2005US20050239099 27 human secreted proteins
10/27/2005US20050238702 Medical composition containing photocrosslinkable chitosan derivative
10/27/2005US20050238670 Immunology response intensifiers; administering a bacterial lysate, for inducing an immune response to Staphylococcus aureus infections
10/27/2005US20050238593 Compositions containing dolichol for dermatological and cosmetic use
10/27/2005DE202005010676U1 Gel, useful for the treatment of summer eczema, comprises onion bulbs, garlic cloves, sugar, water and starch
10/27/2005DE102004016683A1 Dauerhaft geschäumte Zusammensetzung Permanently foamed composition
10/27/2005CA2563870A1 Pharmaceutical compositions comprising old man's beard (usnea barbata) and st.john's wort (hypericum perforatum) and their use
10/27/2005CA2562614A1 Use of treprostinil to treat neuropathic diabetic foot ulcers
10/27/2005CA2562391A1 Solid pharmaceutical preparation
10/27/2005CA2561014A1 Thioamide derivatives as progesterone receptor modulators
10/26/2005EP1589009A1 Vitamin d3 lactone derivative
10/26/2005EP1589006A1 Oxa- and thiazole derivatives useful as antidiabetics and antidiobesity agents
10/26/2005EP1588718A1 Gene therapy of hepatocyte growth factor to enhance muscular and cutaneous flap survival
10/26/2005EP1588706A2 Use of AT1 receptor antagonists or AT2 receptor modulator for the treatment of conditions or diseases associated with the increase of AT1 or AT2 receptors.
10/26/2005EP1588692A1 Durable foamed composition
10/26/2005EP1587834A2 Uses of mammalian cytokine; related reagents
10/26/2005EP1587779A1 5,6,7,8-tetrahydronaphthalen-2-yl 2,6-difluoroheptatrienoic acid derivatives having serum glucose reducing activity
10/26/2005EP1587505A2 Wound and skin care compositions
10/26/2005EP1587486A2 Care or make-up composition comprising a 2-alkylideneaminooxyacetamide, its use for stimulating the growth of the hair or eyelashes and/or slowing down their loss
10/26/2005EP1587477A2 Odorless formulation for treating mucosal discontinuities
10/26/2005EP1534213A4 Water-based delivery systems
10/26/2005EP1430056B1 Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)one derivatives for neurodegenerative disorders
10/26/2005EP1165035B1 Cosmetic compositions containing at least one substance for increasing the functionality and/or expression of cd44 membrane receptors of skin cells
10/26/2005EP1140000B1 Cosmetic or dermatological composition containing an active principle stimulating hsp 32 protein synthesis in the skin and cosmetic treatment method
10/26/2005EP1109559B1 Inhibition of pathogenic processes related to tissue trauma
10/26/2005EP0896521B1 Composition, barrier film, and method for preventing contact dermatitis
10/26/2005CN1688603A Treatment and prophylaxis with 4-1BB-binding agents
10/26/2005CN1688578A Phosphodiesterase 4 inhibitors
10/26/2005CN1688577A Triazaspiro [5.5] undecane derivatives and drugs comprising the same as the active ingredient
10/26/2005CN1688572A Piperidinyl targeting compounds that selectively bind integrins
10/26/2005CN1688553A Chemical process
10/26/2005CN1688550A 2, 5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase MMP12
10/26/2005CN1688549A Compound having TGF-beta inhibitory activity and medicinal composition containing the same
1 ... 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 ... 1065